![Gary J. G. Atkinson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Gary J. G. Atkinson
Fondatore presso Zylö Therapeutic, Inc.
Posizioni attive di Gary J. G. Atkinson
Società | Posizione | Inizio | Fine |
---|---|---|---|
Zylö Therapeutic, Inc.
![]() Zylö Therapeutic, Inc. BiotechnologyHealth Technology Zylö Therapeutic, Inc. develops a drug-delivery system designed to deliver notoriously hard-to-deliver therapeutic agents. The frim offers patented platform technology that leverages hydrogel-derived nanoparticles to deliver in a sustained and controlled manner therapeutic agents through topical administration, enabling the healthcare industry to harness the therapeutic potential across a variety of applications. The company was founded by Scott R. Pancoast, Joel M. Friedman, Adam Friedman, Lance M. White and Gary J. G. Atkinsonin November 2017 in and is headquartered in Greenville, SC. | Direttore/Membro del Consiglio | 01/11/2017 | - |
Fondatore | 01/11/2017 | - |
Storia della carriera di Gary J. G. Atkinson
Precedenti posizioni note di Gary J. G. Atkinson
Società | Posizione | Inizio | Fine |
---|---|---|---|
Quorex Pharmaceuticals, Inc.
![]() Quorex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quorex Pharmaceuticals, Inc. was previously engaged in discovering and developing drugs to address the growing need for new therapies to treat bacterial infections. The company's was purchased by Pfizer Inc in 2005. Quorex was headquartered in Carlsbad, CA. | Direttore Finanziario/CFO | 01/01/2001 | 01/01/2005 |
IONIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/1995 | 01/01/2000 |
Lpath, Inc.
![]() Lpath, Inc. BiotechnologyHealth Technology Lpath, Inc. operates as a biotechnology company, which focuses on the discovery and development of lipidomic-based therapeutic antibodies, an emerging field of medical science that targets bioactive signaling lipids to treat a wide range of human diseases. It develops three drug candidates, each of them into clinical trials, and built evidence to support their approach of targeting bioactive lipids to treat a wide range of diseases. The company was founded by Roger Allen Sabbadini in September 1997 and is headquartered in San Diego, CA. | Amministratore Delegato | 30/09/2015 | - |
Direttore Finanziario/CFO | 01/01/2005 | - | |
Segretario Aziendale | 01/01/2005 | - |
Formazione di Gary J. G. Atkinson
Brigham Young University | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 6 |
Posizioni
Director of Finance/CFO | 2 |
Chief Executive Officer | 1 |
Corporate Secretary | 1 |
Settori
Health Technology | 5 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
IONIS PHARMACEUTICALS, INC. | Health Technology |
Aziende private | 3 |
---|---|
Quorex Pharmaceuticals, Inc.
![]() Quorex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quorex Pharmaceuticals, Inc. was previously engaged in discovering and developing drugs to address the growing need for new therapies to treat bacterial infections. The company's was purchased by Pfizer Inc in 2005. Quorex was headquartered in Carlsbad, CA. | Health Technology |
Lpath, Inc.
![]() Lpath, Inc. BiotechnologyHealth Technology Lpath, Inc. operates as a biotechnology company, which focuses on the discovery and development of lipidomic-based therapeutic antibodies, an emerging field of medical science that targets bioactive signaling lipids to treat a wide range of human diseases. It develops three drug candidates, each of them into clinical trials, and built evidence to support their approach of targeting bioactive lipids to treat a wide range of diseases. The company was founded by Roger Allen Sabbadini in September 1997 and is headquartered in San Diego, CA. | Health Technology |
Zylö Therapeutic, Inc.
![]() Zylö Therapeutic, Inc. BiotechnologyHealth Technology Zylö Therapeutic, Inc. develops a drug-delivery system designed to deliver notoriously hard-to-deliver therapeutic agents. The frim offers patented platform technology that leverages hydrogel-derived nanoparticles to deliver in a sustained and controlled manner therapeutic agents through topical administration, enabling the healthcare industry to harness the therapeutic potential across a variety of applications. The company was founded by Scott R. Pancoast, Joel M. Friedman, Adam Friedman, Lance M. White and Gary J. G. Atkinsonin November 2017 in and is headquartered in Greenville, SC. | Health Technology |
- Borsa valori
- Insiders
- Gary J. G. Atkinson
- Esperienza